Radiometallic Complexes of DO3A-Benzothiazole Aniline for Nuclear Medicine Theranostics.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Pharmaceutics

• Publication date

  2018-01-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.molpharmaceut.7b00996PMID 29381860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3

  2016cited by this paper
• Development of peptide and protein based radiopharmaceuticals.

  2014cited by this paper
• PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques.

  2013cited by this paper
• Recent advances in radiopharmaceutical application of matched-pair radiometals.

  2013cited by this paper
• Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans

  2013cited by this paper
• New bifunctional chelator for 64Cu-immuno-positron emission tomography.

  2013cited by this paper
• Gadolinium complex of DO3A-benzothiazole aniline (BTA) conjugate as a theranostic agent.

  2013cited by this paper
• The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

  2013cited by this paper
• Tumour targeting with radiometals for diagnosis and therapy.

  2013cited by this paper
• Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.

  2013cited by this paper
• Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

  2012cited by this paper
• Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives as Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation

  2012cited by this paper
• Small-Animal PET: What Is It, and Why Do We Need It?*

  2012cited by this paper
• Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for β-amyloid plaques in Alzheimer's brains.

  2012cited by this paper
• Benzothiazoles: search for anticancer agents.

  2012cited by this paper
• Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors.

  2012cited by this paper
• PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference

  2011cited by this paper
• Matched pairs for radionuclide-based imaging and therapy

  2011cited by this paper
• Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

  2010cited by this paper
• Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease.

  2009cited by this paper
• A simple Cu-64 production and its application of Cu-64 ATSM.

  2009cited by this paper
• Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain.

  2008cited by this paper
• Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

  2006cited by this paper
• Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.

  2006cited by this paper
• Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

  2004cited by this paper
• The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.

  2004cited by this paper
• Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

  2003cited by this paper
• Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.

  2003cited by this paper
• Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2.

  2002cited by this paper
• The anti-malarial artesunate is also active against cancer.

  2001cited by this paper
• The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.

  2001cited by this paper
• Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images

  2000cited by this paper
• Radiometal-labeled agents (non-technetium) for diagnostic imaging.

  1999cited by this paper
• 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.

  1998cited by this paper
• Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.

  1996cited by this paper

• Advances in macrocyclic chelators for positron emission tomography imaging

  2023cites this paper
• N,N-Alkylation Clarifies the Role of N- and O-Protonated Intermediates in Cyclen-Based 64Cu Radiopharmaceuticals.

  2022cites this paper
• Facile activation of the C–I bond of primary alkyl halides by Pt(II) complexes having a benzothiazole ligand

  2020cites this paper
• Synthesis and evaluation of Al18F-NODA complex conjugated 2-(4-aminophenyl)benzothiazole as a potential tumor imaging agent.

  2020cites this paper